Eduardo Stadelmann

Leading the transformation in Orthopedics with digital & robotic technologies and data solutions.

Managing successfully the P&L of Zimmer Biomet in the market Switzerland, with a team of approx. 70 individuals

Managed the P&L of the key and strategic market Switzerland. Led successfully a team of approsx. 55 individuals.

Managed the P&L of the key emerging market Latin America.

Led successfully a full fledged European logistics team (forecasting, planning, warehousing, customer service, master data), with pan-European responsibility.

Led integration project from which the company realized savings. Orchestrated multiple European functional teams towards common goal and to deliver on deadlines and targets.

Led successfully the finance & administration, logistics, and IT teams. Focused on solving key logistics issues (e.g. consignment inventory) and a very critical accounts receivable situation.

Led various M&A projects, including strategic assessment, financial valuation, coordination of due diligence analysis, formal application to the Board of Directors, and price and contract negotiations. M&A projects ranged from: business line acquisition to enter a new market segment, acquisitions to establish direct operations

Developed and subsequently implemented strategy to pursue out-licensing opportunities. Led business discussions with industry partners that were potentially interested in licensing the company’s core technology. Led various strategic tasks in support of senior executive management, e.g. portfolio analysis of R&D projects, preparation of company’s operating plan, preparation of application documents to the Board of Directors.

Supported senior executive management in developing strategic plans; reviewed and assessed these plans on behalf of the Corporate Executive Management. Benchmarked financial performance against competitors using the economic value added model. Consulted Sulzer Orthopedics. Supported Sulzer Infra. Performed strategic assessment and financial valuation for several acquisitions. Led and managed various divestiture and management buy-out projects.

Led new product development in accordance with ISO 9001/EN 46001 and GMP directives. Directed the development of new products from conception to in vitro tests, to clinical trials, to mass-production, as well as the re-design of existing products, and the manufacturing of custom-made products for key customers. Re-engineered the company’s product design process as part of ISO 9001 certification and organized the compilation of relevant information for PMA submission to FDA.

Biomedical Engineering